Diagnostics not part of Hoechst spin-off
This article was originally published in Clinica
Executive Summary
The diagnostics business of German group Hoechst will not be part of Hoechst Marion Roussel, the pharmaceutical division which may be floated in part or as a whole in 1997. The diagnostics business, Behring Diagnostics, remains part of the chemicals, fibres and agricultural slice of Hoechst.